Announcement on the progress of entrusted financial management
Release time:
2020-08-05
证券简称:尖峰集团 证券代码:600668 编号:临2017-031
债券简称:13尖峰01 债券代码:122227
债券简称:13尖峰02 债券代码:122344
浙江尖峰集团股份有限公司
关于委托理财进展情况的公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
l 委托理财受托方:招商银行股份有限公司金华江北支行
l 委托理财金额:3000万元人民币
l 委托理财投资类型:保本浮动收益型结构性存款
l 委托理财期限:2017年10月10—2017年11月13日
一、本次委托理财概述
(一)本次委托理财的基本情况
公司于2017年10月10日与招商银行股份有限公司金华江北支行(以下简称“招商银行金华江北支行”)签署《招商银行单位结构性存款协议》,公司出资3,000万元人民币购买招商银行金华江北支行发售的单位结构性存款CHZ00318号理财产品,产品期限34天,预期年化收益率3.85%。本产品为保本浮动收益型理财产品。公司本次投资委托理财产品的资金来源为公司自有资金,且本次委托理财不构成关联交易。
(二)公司内部需履行的审批程序。
2015年4月17日,公司召开第九届董事会第2次会议审议通过了《关于授权公司董事长利用闲置自有资金进行委托理财等投资的议案》,授权公司董事长利用闲置自有资金进行委托理财等投资,最高不超过人民币1亿元,在该额度内资金可以滚动使用,每笔投资业务的期限均不得超过12个月。详见本公司在2015年4月21日在上海证券交易所网站披露的《关于授权董事长决定委托理财等投资的公告》(临2015-008)。
2017年8月25日,公司召开的第九届董事会第15次会议审议通过了《关于授权公司董事长决定委托理财的议案》。授权公司董事长行使不超过人民币2亿元的委托理财的决策权,在该额度内资金可以滚动使用,但任一时点存续的委托理财余额合计不得超过2亿元,每笔委托理财的期限均不得超过12个月。详见本公司在2017年8月29日在上海证券交易所网站披露的《关于授权董事长决定委托理财的公告》(临2017-024)。
公司本次购买招商银行金华江北支行结构性存款CHZ00318号理财产品,在公司第九届董事会第15次会议授权董事长决策范围之内。
二、本次委托理财协议主体的基本情况
1、交易对方名称:招商银行股份有限公司金华江北支行,公司类型:股份有限公司分公司(上市),营业场所:浙江省金华市婺城区解放东路268号莲花大夏附楼,负责人:胡刚,经营范围:经营总行在中国银行监督管理委员会批准的业务范围内授权的业务。
2、招商银行股份有限公司金华江北支行与本公司之间在产权、业务、资产、债权债务、人员等方面均不存在关联关系。
三、 本次委托理财合同的主要内容
(一)基本说明
公司本次购买理财产品的资金来源为公司自有资金,委托理财期限为2017年10月10日至2017年11月13日。招商银行江北支行结构性存款产品为保本保底利息浮动收益型理财产品,预期年化收益率为3.85%,无需提供履约担保。本产品收益的计算中已包含(计入)银行的运营管理成本(如账户监管、资金运作管理、交易手续费等),公司无需支付或承担本产品下的其他费用或收费。
(二)产品说明
1、投资方向以及范围
结构性存款是指以企业的存款作为本金,挂钩利率、汇率、股票指数、商品价格等金融市场指标的创新型存款产品。如果投资方向正确,将获得额外收益;如果方向失误,将损失购买期权的费用,对于本金不造成影响。
2、收益计算
(1)本结构性存款产品到期日,由招商银行江北支行全额返还结构性存款本金及支付保底利率1.15%(年化)。
(2)本结构性存款产品收益兑付日,由招商银行江北支行根据预设条件支付结构性存款浮动收益。
(3)当发生政策风险或其他不可抗力因素时,收益保证条款不适用。
(4)浮动收益获得条件:如果存款存续期间内,伦敦金市下午定盘价在到期观察日未能突破波动区间【“期初价格-400美元”至“期初价格+400美元”(含边界)】,则本存款到期浮动利率2.7%(年化);如果存款存续期间内,伦敦金市下午定盘价在到期观察日突破波动区间【“期初价格-400美元”至“期初价格+400美元”(含边界)】,则本存款到期浮动利率为0。
(5)提前终止:本产品存续期内,公司与招商银行江北支行均无权提前终止本存款。
3、收益兑付
(1)本金及保底利息支付:结构性存款到期日,以转账方式将本金及保底利息转入公司原转存账户。
(2)收益支付:结构性存款收益兑付日,将浮动收益(如有)划入公司原转存帐户。
4、产品特点
该产品风险较小,适合对于利率、汇率、股票指数、商品价格等走势有一定见解和看法的投资人,并且为客户设置本金及保底利息保护,一定程度上降低了风险。
(三)敏感性分析
公司本次以自有资金3000万元购买的招商银行金华江北支行结构性存款CHZ00318号理财产品期限较短,不会对公司生产经营状况造成影响。在该投资期限内减少公司现金流净额3000万元,到期后预期为公司产生收益10.76万元。
(四)风险控制分析
本理财产品为保本收益型产品,银行确保公司本金安全,符合公司维护全体股东和公司利益的原则。公司始终将委托理财产品风险防控工作放在首位,严格按照内控制度有关规定,投资委托理财产品均为期限短、安全性高、流动性好的低风险银行理财产品。公司对购买的理财产品严格把关,谨慎决策。
四、截至本公告日,公司累计进行委托理财的金额。
(一)尚未到期的理财产品
|
序号 |
受托人 |
理财产品类型 |
金额 (万元) |
起始日 |
到期日 |
|
1 |
广发银行金华分行 |
薪加薪16号J352人民币结构性存款产品 |
4,000.00 |
2017/7/28 |
2017/11/13 |
|
2 |
广发银行金华分行 |
薪加薪16号XJXCKJ0577人民币结构性存款产品 |
4,000.00 |
2017/9/14 |
2017/11/29 |
|
3 |
招商银行金华江北支行 |
招商银行结构性存款CHZ00318 |
3,000.00 |
2017/10/10 |
2017/11/13 |
(二)连续十二个月内到期已收回本息的理财产品
|
序号 |
受托人 |
理财产品类型 |
金额 (万元) |
起始日 |
到期日 |
截止公告日已收回本金金额(万元) |
截止公告日获得收益(万元) |
|
1 |
广发银行金华分行 |
薪加薪16号5876人民币结构性存款产品 |
5,000.00 |
2017/4/6 |
2017/7/5 |
5,000.00 |
51.16 |
|
2 |
渤海银行金华分行 |
渤海银行S17180号结构性存款理财产品 |
3,000.00 |
2017/5/17 |
2017/6/19 |
3,000.00 |
10.58 |
|
3 |
渤海银行金华分行 |
渤海银行S17265号结构性存款理财产品 |
3,000.00 |
2017/6/23 |
2017/7/27 |
3,000.00 |
12.30 |
|
4 |
广发银行金华分行 |
薪加薪16号J0253人民币结构性存款产品 |
4,000.00 |
2017/7/6 |
2017/10/9 |
4,000.00 |
44.66 |
(三)公司连续十二个月内累计委托理财金额
截止本公告日,公司连续十二个月内使用闲置自有资金进行委托理财的累计金额2.6亿元,其中:到期已收回1.5亿元,尚未到期的1.1亿元。
公司无其他未披露的委托理财事项。
特此公告
浙江尖峰集团股份有限公司
董事会
二〇一七年十月十二日
More information
Spike Health was identified as Zhejiang Agricultural Science and Technology R & D Center
Zhejiang Provincial Department of science and technology recently issued a notice, peak health technology company research and development center was identified as Zhejiang agricultural science and technology research and development center. According to the relevant requirements, Zhejiang agricultural science and technology research and development center must be established with national and provincial agricultural leading enterprises, agricultural science and technology enterprises or other scientific and technological agricultural enterprises with high scientific and technological content as the carrier, with strong economic strength and scientific and technological research and development foundation; The annual sales income of the enterprise is more than 10 million yuan, and the R & D center has more than 10 full-time technicians, of whom more than 30% have bachelor's degree or above; the annual technology development funds shall not be less than 3% of the sales revenue of the enterprise; it has the necessary instruments and equipment and fixed and special places to meet the research and development; it has the conditions for the application of agricultural technology information network. The main business of the enterprise is clear, and it is the priority industry in our province. The technological innovation achievements have a wide range of radiation, the enterprise system is sound, and the operating mechanism is good. With the domestic, provincial institutions of higher learning, scientific research units have established a stable relationship of scientific research cooperation. Since its establishment, Jianfeng Health has attached great importance to the construction of innovation platform and the cultivation of scientific and technological talents. In 2016, it has been recognized as Jinhua agricultural science and technology enterprise and municipal agricultural science and technology research and development center. In 2017, research and development investment accounted for 5.06 of sales revenue, and full-time research and development personnel with bachelor's degree or above accounted for 80.9, consisting of talents including traditional Chinese medicine, traditional Chinese medicine preparation, agriculture and biotechnology, pharmacy, analysis, plant extraction, food engineering, etc. Dr. Li Wende, head of the research and development center, was also selected "Jinhua Shuanglong plan talent" in 2017 ". In recent years, peak health and Zhejiang workers.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-30
Editor's note: On November 20, the first page of "Jinhua Daily" published "Focus on sticking to the peak forever-Enlightenment of Jianfeng Group's 60 years of entrepreneurship" written by the reporter of the newspaper, which was specially reprinted by this newspaper. Focus on sticking to the peak forever-Jianfeng Group's 60 years of entrepreneurship enlightenment "Jinhua Daily" reporter Shao Xuilian as of the end of the third quarter of this year, the total assets of 4.788 billion yuan, net assets of 3.366 billion yuan, the realization of the parent company's net profit of 0.488 billion yuan, earnings per share of 1.42 yuan. Recently, Jianfeng Group disclosed its beautiful report for the third quarter of 2018, celebrating its 60th anniversary with the best operating results in history. Wind and rain for 60 years. With sustained and steady high-quality development, the peak people are moving towards a comprehensive modern enterprise group with strong core competitiveness. Strategy: Focus and Professionalism In 1958, the first generation of peak people built the first cement factory in Jinhua history at the foot of peak mountain. Beginning in 1983, through horizontal alliances with township enterprises, the formation of enterprise groups, and the implementation of shareholding reforms, Jianfeng has developed from a small state-owned cement plant to the first listed company in China's cement industry. Since then, in the stage of diversification, the peak will develop the pharmaceutical industry into the second pillar industry. In 2007, it joined forces with the central enterprise China Building Materials to participate in the establishment of Southern Cement and strategically shifted the focus of the cement industry; at the same time, through corporate mergers and acquisitions and technological innovation, the pharmaceutical industry has further exerted its strength. Today, Jianfeng Group has 33 participating and holding subsidiaries, involving building materials, medicine, big health, modern logistics, national.
2020
07-31
News from our newspaper On the occasion of the celebration of the 60th anniversary of Jianfeng's entrepreneurship, the selection results of the two competitions of "Me and Jianfeng" essay and employee calligraphy and painting photography exhibition are also fresh. Since July 2017, more than 50 contributions have been received from employees and their families. According to the overall situation of the content and writing level of the solicitation, 3 first prize works, 5 second prize works and 7 third prize works were selected. The staff calligraphy and painting photography exhibition began to call for contributions in early April. in just five months, it received more than 100 works from dozens of authors from various enterprises under the group, and successfully held the exhibition from October 10 to 17, which was welcomed and praised by the majority of employees. After a comprehensive selection of employee contributions, a total of 3 first-class works, 5 second-class works, and 7 third-class works were selected. In order to ensure the fairness and impartiality of the selection, the works of the leading group, working group members and specially invited works to commemorate the 60th anniversary of Jianfeng Entrepreneurship will not participate in the selection of the grade award. (The list of winners is attached) (This reporter) "I and the peak" essay list first prize "mother and son deep love" author: Daye peak Shi Fu "I have a date with the peak" author: Yunnan peak Luo Meiyan "buying a house" author: peak cable Lu Chaofang second prize "ten years, sixty years" author: pharmaceutical sales company Xu Yuting "my peak road" author: daye Peak Yang Zhendong's "My Teacher" Author: Fan Tufa, Municipal Pharmaceutical Company, "Peak Grows with Me for 20 Years" Author: Xu Junxiong, Pharmaceutical Sales Company, "Peak Grows with Me"
2020
07-31